Viral protein R (Vpr), one of the human immunodeficiency virus type 1 (HIV-1) accessory proteins, contributes to multiple cytopathic effects, G 2 cell cycle arrest and apoptosis. The mechanisms of Vpr have been intensely studied because it is believed that they underlie HIV-1 pathogenesis. We here report a cell-based small molecule screen on Vpr induced cell death in the context of HIV-1 infection. From the screen of 504 bioactive compounds, we identified damnacanthal (Dam), a component of noni fruit, as an inhibitor of Vpr induced cell death. Our studies illustrate a novel efficient platform for drug discovery and development in anti-HIV therapy which should also be applicable to other viruses.
Therapeutic agents currently available against human immunodeficiency virus type 1 (HIV-1) target viral proteins directly [1] . Although these agents have dramatically reduced the rate of disease progression and improved the lifestyles in HIV infected patients, a fast mutating nature of HIV-1 and persistent production of low level viruses from latently infected T cells give rise to drug resistant strains and thus urgently necessitate the discovery of more novel agents [2, 3] . An attractive alternative to develop such agents is through modulation of the immune system against HIV. It is clear that immune dysfunction is critical for the development of acquired immune deficiency syndrome (AIDS). The disease is characterized by high viral burden and ongoing and extensive lymphocyte cell death [4] [5] [6] . However, the mechanism of cell death remains unclear.
The 14 kDa HIV-1 viral protein R (Vpr) is one of the viral factors that regulate HIV-1 pathogenesis and HIV-1 dependent lymphocyte apoptosis [7] . Vpr is encoded in the HIV genome and packaged in the virion via its association with the structural protein Gag p6. In the past, Vpr was not considered to be biologically important as it was not required for viral replication in established cell lines or in activated or resting T cells [8] . Recent studies clearly showed that Vpr is indispensable for disease progression in rhesus monkeys [9] and in chimpanzees [10] . Non-functional Vpr mutations are also observed in patients with slow progression to AIDS [11] [12] [13] , suggesting that targeting Vpr inhibition may be a beneficial strategy in AIDS therapy.
Vpr is highly conserved among the primate lentiviruses HIV-1, HIV-2, and SIV, suggesting its important role in the viral life cycle. Vpr is a pleiotropic protein with multiple pathobiological mechanisms. These mechanisms include nuclear import of preintegration complex [14] , transactivation of several viral promoters including long terminal repeat (LTR) [15, 16] , and induction of cell cycle arrest at G 2 /M phase (G 2 arrest) [17] and apoptosis [18, 19] . Apoptosis induced by Vpr is believed to contribute to CD4+ T cell depletion [17, 20] . Virion associated Vpr is sufficient to induce G 2 arrest and apoptosis selectively in several proliferating cell lines [21] . Many studies have shown that Vpr induced apoptosis is similar to c-irradiation induced-apoptosis [22] , dependent on caspase activation [19] and independent of the p53 tumor suppressor gene [21] .
We here show that a small molecule screen can provide signaling probes to dissect Vpr mechanisms and elucidate novel therapeutic agents for anti-HIV therapy. We screened 504 bioactive small molecules and identified damnacanthal (Dam), a component of noni fruit (Morinda citrifolia), as an inhibitor of Vpr dependent cell death.
Materials and methods
Cell, virus like particles (VLP), and lentiviral vectors. HeLa cells were cultured and maintained in DMEM containing 10% FBS supplemented with penicillin/streptomycin/glutamine mixture.
VSV-G envelope pseudotyped RNA(À) VLP with or without Vpr (Vpr+/VLP or VprÀ/VLP, respectively) was generated by cotransfection with either pCMVDR8.2 or pCMVDR8.2DVpr, and pCMV VSV-G, respectively, as described previously [21] . Flag-tagged Vpr encoding lentiviral vector (Vpr+/CCR-X) or control vector (VprÀ/CCR-X) was produced by cotransfection of pRRL-cPPT-CMV-PRE-SIN [23] , which carries Flag-tagged Vpr sequence [24] with or without stop codon right after Flag tag sequence, pCMVDR8.2DVpr, and pCMV VSV-G, respectively. VLPs and the lentiviral vectors were harvested, concentrated as described previously [25] , and titrated to ensure that approximately 50% (for Vpr+/VLP) and 90% (for Vpr+/CCR-X) of HeLa cells were arrested in G 2 phase at 24 h postinfection.
Screening protocol. 1 · 10 6 HeLa cells were infected with 10 lg (p24 equivalent) of Vpr+/VLP or VprÀ/VLP in the presence of 8 lg/ml polybrene for 2 h. Cells were rinsed with fresh medium for six times, trypsinized, and 500 cells in 25 ll of medium were replated in each well of a 384-well (white) microtiter plate (Corning) Compounds were transferred to the assay plates using 384-pin arrays (Genetix). The cells were incubated at 37°C under 5% CO 2 for 72 h before cell viability was accessed.
Cell viability assay. Cell viability was accessed using CellTiter-Glo Cell cycle profiles and sub-G 1 peak analyses. HeLa cells were infected with VLPs (1 lg of p24 per 1 · 10 5 cells) or with lentiviral vectors (200 ng of p24 per 1 · 10 5 cells) and collected using the protocol similar to that used for annexin V staining. The cell pellets were then fixed with ice-cold 70% ethanol and stained with propidium iodide (Sigma-Aldrich). A total of 10,000 events were collected by FACScan for cell cycle status and sub-G 1 peak as previously described [26] and analyzed with ModFit LTä software (Verity Software House).
Statistical analysis. The raw data of untreated samples were converted to the frequency of luminescent units using the histogram function in Microsoft Excel Data Analysis ToolPak (Microsoft). Normal distribution function was used to fit the frequency values to Gaussian distribution and to test significance of treated data from untreated samples.
Results and discussion
A phenotype-based small molecule screen for inhibitors of Vpr cytotoxicity
To identify novel small molecule probes that inhibit Vpr induced cell growth cessation which is mainly caused by apoptosis and G 2 arrest, we screened small molecule libraries against VSV-G pseudotyped VLP containing Vpr in the virion. As previously described, VLP lacks the RNA genome necessary for de novo synthesis of viral proteins, but contains Vpr in association with virion Gag p6. Virion associated Vpr is sufficient to induce G 2 arrest as well as apoptosis [21] . We used HeLa cells for the screen because HeLa cells are most sensitive to Vpr-induced apoptosis [21] .
The screen identified damnacanthal (Dam), an anthraquinone derivative, as an inhibitor of Vpr induced cell growth cessation (Fig. 1) . Dam was first isolated from noni fruit, a traditional Tahaitian fruit commonly used as a folk medicine by Polynesians for over 2000 years [27] . It has been reported that Dam reverts the morphology of K-ras transformed cells to normal one [28] and that Dam inhibits p56 lck tyrosine kinase in in vitro kinase assay [29] . Dam inhibited Vpr induced cell growth cessation by twofold with more than 7 standard deviations from untreated Vpr infected cells (Fig. 1B and C) . This effect of Dam was confirmed both in a replicate secondary screen and in assays using lentiviral vector encoded Vpr (Vpr+/CCR-X) (data not shown). The effect on cell viability was also measured in a different assay using traditional Trypan blue staining, which indicated that Dam increased total viable cell number 1.5-fold compared to control Vpr+/VLP or Vpr+/ CCR-X infected cells.
Damnacanthal inhibits Vpr dependent apoptosis without affecting the induction of G 2 arrest
To determine inhibitory mechanisms of Dam on Vpr induced cell growth cessation, we first examined cell cycle profiles of VLP-infected cells. 44.3% of Vpr+/VLP infected cells arrest at G 2 phase at 24 h postinfection and 44.7% of Vpr+/VLP infected cells remained arrested at G 2 in the presence of Dam. Beyond 24 h, the VLP system did not allow us to determine whether Dam affects Vpr induced G 2 arrest because Vpr effect is relieved over time in this system ( Fig. 2A) . However, Dam significantly inhibited Vpr induced accumulation of sub-G 1 cells at 60 h postinfection by approximately 30%. Annexin-V staining indicated that these sub-G 1 cells were partly derived from dead cells by apoptosis and that Dam suppressed approximately 11% of Vpr induced apoptosis (Fig. 2B) . The discrepancy between sub-G 1 measurement and annexin-V staining can be explained by Dam's inhibition of multiple cell death pathways in addition to apoptosis.
To determine whether Dam affects induction of G 2 arrest by Vpr more clearly, we used a recombinant lentiviral vector encoding Vpr (Vpr+/CCR-X). We infected a population of synchronized HeLa cells released from a double thymidine block at the G 1 /S border as previously described [22] . Infection of Vpr+/CCR-X arrested a majority of infected cells in G 2 +M phase at 12 h postinfection (Fig. 3A) . We added Dam to the infected cell culture at the time of infection and analyzed cell cycle 
Damnacanthal inhibits cell death without affecting Vpr's G 2 maintenance
To determine the effect of Dam on Vpr's G 2 maintenance, we infected HeLa cells released from double thymi- (Fig. 3B) . The increased number of G 1 population is not a consequence of perturbation on G 2 arrest because the total cell number decreased and more fragmented DNAs increased over time (data not shown).
In Interestingly, a previous screen by Ali et al. identified Dam as an agent that protects against cytotoxicity caused by HIV [30] . Their screen was performed on CEM-SS cell infected with HIV and the mechanism of inhibition has remained unknown. Here, we identified Dam directly as an inhibitor of cell death caused by a specific HIV protein, Vpr, and demonstrated that Dam inhibits Vpr induced cell death partly by the anti-apoptotic function. Furthermore, our HIV infection experiment using human peripheral blood lymphocytes showed that Dam inhibited p24 production by 52% and 33% at day 5 and 7 after the infection, respectively (data not shown), suggesting that Dam might work as an anti-AIDS agent by suppressing HIV production and inhibiting CD4+ cell depletion in patients.
Vpr has been shown to induce apoptosis by inducing prolonged cell cycle arrest [18, 31] . On the other hand, Vpr has also been shown to induce apoptosis independent of G 2 arrest [32] . We here provide evidence using an inhibitor of Vpr dependent cell death that small molecules can be used to divide Vpr induced cell death mechanisms. The mechanism(s) on how Dam inhibits Vpr induced apoptosis is currently unknown and will need to be elucidated. Identification of small molecules that inhibit Vpr induced cell death not only provides mechanistic insights into how Vpr regulated cell cycle arrest and apoptosis, but it may also enhance our understanding and treatment for other diseases with deregulated apoptosis and cell cycle.
